Xencor, Inc Interest Expense
Xencor, Inc (XNCR) reported Interest Expense of $9.68 million for the 3-month period ending 2024-03-31, per its 10-Q/A filed 2025-02-24.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2025-02-24
- Xencor, Inc interest expense for the quarter ending 2024-03-31 was $9.68M, a 138128.57% increase year-over-year.
- Xencor, Inc interest expense for the quarter ending 2023-03-31 was $7.00K.
- Xencor, Inc interest expense for the quarter ending 2018-06-30 was $3.00K, a 0.00% change year-over-year.
- Xencor, Inc interest expense for the quarter ending 2018-03-31 was $4.00K, a 33.33% increase year-over-year.
- Xencor, Inc interest expense for fiscal 2023 was $6.18M, a 47415.38% increase from fiscal 2022.
- Xencor, Inc interest expense for fiscal 2022 was $13.00K, a 0.00% change from fiscal 2021.
- Xencor, Inc interest expense for fiscal 2021 was $13.00K.
- Xencor, Inc interest expense for fiscal 2018 was $16.00K, a 23.08% increase from fiscal 2017.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $9.68M 10-Q/A · filed 2025-02-24 | |||
| 2023-12-31 | $6.18M 10-K/A · filed 2025-02-24 | |||
| 2023-03-31 | $7.00K 10-Q/A · filed 2025-02-24 | |||
| 2022-12-31 | $13.00K 10-K/A · filed 2025-02-24 | |||
| 2021-12-31 | $13.00K 10-K/A · filed 2025-02-24 | |||
| 2018-12-31 | $16.00K 10-K · filed 2019-02-26 | |||
| 2018-06-30 | $3.00K 10-Q · filed 2018-08-07 | $6.00K 10-Q · filed 2018-08-07 | $12.00K derived: sum of 3 quarters · filed 2019-02-26 | $15.00K derived: sum of 4 quarters · filed 2019-02-26 |
| 2018-03-31 | $4.00K 10-Q · filed 2018-05-07 | $9.00K derived: sum of 2 quarters · filed 2019-02-26 | $12.00K derived: sum of 3 quarters · filed 2019-02-26 | $15.00K derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $8.00K derived: sum of 2 quarters · filed 2019-02-26 | $11.00K derived: sum of 3 quarters · filed 2019-02-26 | $13.00K 10-K · filed 2019-02-26 |
| 2017-09-30 | $3.00K 10-Q · filed 2018-11-05 | $6.00K derived: sum of 2 quarters · filed 2018-11-05 | $8.00K 10-Q · filed 2018-11-05 | -$9.00K derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $3.00K 10-Q · filed 2018-08-07 | $5.00K 10-Q · filed 2018-08-07 | -$12.00K derived: sum of 3 quarters · filed 2019-02-26 | -$10.00K derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $3.00K 10-Q · filed 2018-05-07 | -$15.00K derived: sum of 2 quarters · filed 2019-02-26 | -$13.00K derived: sum of 3 quarters · filed 2019-02-26 | -$3.00K derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | -$18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$16.00K derived: sum of 2 quarters · filed 2019-02-26 | -$6.00K derived: sum of 3 quarters · filed 2019-02-26 | $21.00K 10-K · filed 2019-02-26 |
| 2016-09-30 | $2.00K 10-Q · filed 2017-11-08 | $12.00K derived: sum of 2 quarters · filed 2017-11-08 | $39.00K 10-Q · filed 2017-11-08 | $41.00K derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | $10.00K 10-Q · filed 2017-08-07 | $37.00K 10-Q · filed 2017-08-07 | $39.00K derived: sum of 3 quarters · filed 2018-02-28 | $43.00K derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | $27.00K 10-Q · filed 2017-05-10 | $29.00K derived: sum of 2 quarters · filed 2018-02-28 | $33.00K derived: sum of 3 quarters · filed 2018-02-28 | $37.00K derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $6.00K derived: sum of 2 quarters · filed 2018-02-28 | $10.00K derived: sum of 3 quarters · filed 2018-02-28 | $13.00K 10-K · filed 2018-02-28 |
| 2015-09-30 | $4.00K 10-Q · filed 2016-11-02 | $8.00K derived: sum of 2 quarters · filed 2016-11-02 | $11.00K 10-Q · filed 2016-11-02 | $14.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $4.00K 10-Q · filed 2016-08-03 | $8.00K 10-Q · filed 2016-08-03 | $10.00K derived: sum of 3 quarters · filed 2017-03-01 | $12.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $4.00K 10-Q · filed 2016-05-02 | $6.00K derived: sum of 2 quarters · filed 2017-03-01 | $8.00K derived: sum of 3 quarters · filed 2017-03-01 | $11.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $4.00K derived: sum of 2 quarters · filed 2017-03-01 | $7.00K derived: sum of 3 quarters · filed 2017-03-01 | $9.00K 10-K · filed 2017-03-01 |
| 2014-09-30 | $2.00K 10-Q · filed 2015-11-04 | $5.00K derived: sum of 2 quarters · filed 2015-11-04 | $7.00K 10-Q · filed 2015-11-04 | $8.00K derived: sum of 4 quarters · filed 2016-03-08 |
| 2014-06-30 | $3.00K 10-Q · filed 2015-08-05 | $5.00K 10-Q · filed 2015-08-05 | $6.00K derived: sum of 3 quarters · filed 2016-03-08 | $5.00K derived: sum of 4 quarters · filed 2016-03-08 |
| 2014-03-31 | $2.00K 10-Q · filed 2015-05-05 | $3.00K derived: sum of 2 quarters · filed 2016-03-08 | $2.00K derived: sum of 3 quarters · filed 2016-03-08 | $554.00K derived: sum of 4 quarters · filed 2016-03-08 |
| 2013-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08 | $0.00 derived: sum of 2 quarters · filed 2016-03-08 | $552.00K derived: sum of 3 quarters · filed 2016-03-08 | $1.21M 10-K · filed 2016-03-08 |
| 2013-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $551.00K derived: sum of 2 quarters · filed 2014-11-10 | $1.21M 10-Q · filed 2014-11-10 | |
| 2013-06-30 | $552.00K 10-Q · filed 2014-08-01 | $1.21M 10-Q · filed 2014-08-01 | ||
| 2013-03-31 | $661.00K 10-Q · filed 2014-05-15 | |||
| 2012-12-31 | $2.46M 10-K · filed 2015-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |